Overview of the 2022 WHO classification of pituitary adenomas/pituitary neuroendocrine tumors: clinical practices, controversies, and perspectives
X Wan, J Chen, J Wang, Y Liu, K Shu, T Lei - Current Medical Science, 2022 - Springer
The latest edition of the WHO classification of the central nervous system was published in
2021. This review summarizes the major revisions to the classification of anterior pituitary …
2021. This review summarizes the major revisions to the classification of anterior pituitary …
[HTML][HTML] Aggressive and Metastatic Pituitary Neuroendocrine Tumors: Therapeutic Management and Off-Label Drug Use
P Iglesias - Journal of Clinical Medicine, 2023 - mdpi.com
Pituitary neuroendocrine tumors (PitNETs) are the most common pituitary tumors and the
second most common brain tumors. Although the vast majority (> 90%) are benign, a small …
second most common brain tumors. Although the vast majority (> 90%) are benign, a small …
[HTML][HTML] PD-L1 Expression in Pituitary Neuroendocrine Tumors/Pituitary Adenomas
G Cossu, S La Rosa, JP Brouland, N Pitteloud, E Harel… - Cancers, 2023 - mdpi.com
Simple Summary The biological behavior of Pituitary Neuroendocrine Tumors (PitNET)
remains unclear. Many efforts have been performed in order to clarify this point. The …
remains unclear. Many efforts have been performed in order to clarify this point. The …
[HTML][HTML] Aggressive pituitary tumors (PitNETs)
H Nishioka - Endocrine journal, 2023 - jstage.jst.go.jp
The majority of anterior pituitary tumors behave benignly, that is, they grow slowly and do not
metastasize, and were therefore called adenomas. However, they would frequently invade …
metastasize, and were therefore called adenomas. However, they would frequently invade …
[HTML][HTML] Pituitary carcinoma-case series and review of the literature
S Du Four, J Van Der Veken, J Duerinck… - Frontiers in …, 2022 - frontiersin.org
Although pituitary adenomas (PAs) account for 15% of intracranial tumors, pituitary
carcinomas (PCs) are a rare entity. Most commonly, PCs evolve from aggressive PAs …
carcinomas (PCs) are a rare entity. Most commonly, PCs evolve from aggressive PAs …
Differences in invasiveness and recurrence rate among nonfunctioning pituitary neuroendocrine tumors depending on tumor subtype
Purpose To clarify the invasiveness to surrounding structures and recurrence rate of each
subtype of nonfunctioning pituitary neuroendocrine tumor (Pit-NETs) according to the WHO …
subtype of nonfunctioning pituitary neuroendocrine tumor (Pit-NETs) according to the WHO …
Pituitary adenoma & nuclear medicine: Recent outcomes and ongoing developments
B Chevalier, A Jannin, S Espiard, E Merlen, A Beron… - La Presse Médicale, 2022 - Elsevier
In order to explore pituitary adenoma (PA), magnetic resonance imaging (MRI) remains the
cornerstone. However, there are some limitations and MRI can be non-conclusive. The …
cornerstone. However, there are some limitations and MRI can be non-conclusive. The …
[HTML][HTML] The clinical and pathological characteristics of refractory pituitary adenomas: a single center experience
X Liu, C Dai, X Bao, K Deng, Y Yao, M Feng… - Frontiers in …, 2022 - frontiersin.org
Background Most of pituitary adenomas (PAs) are slow-growing benign tumors which can
be cured or controlled by conventional therapies, including surgery, medical treatment or …
be cured or controlled by conventional therapies, including surgery, medical treatment or …
[HTML][HTML] Endoscopic endonasal pituitary surgery: How we do it. Consensus statement on behalf of the EANS skull base section
Introduction and research question The use of an endoscope in skull base surgery provides
a panoramic close-up view over the intracranial structures from multiple angles with …
a panoramic close-up view over the intracranial structures from multiple angles with …
SPECIALTY SECTION This article was submitted to Pituitary Endocrinology, a section of the journal Frontiers in Endocrinology
S Du Four, J Van Der Veken, J Duerinck… - … in Pituitary Disorders, 2024 - books.google.com
Pituitary adenomas are a commonly encountered pathology, with an overall estimated
incidence of 16.7%(1). Most often, pituitary adenomas (PAs) are slow growing tumors that do …
incidence of 16.7%(1). Most often, pituitary adenomas (PAs) are slow growing tumors that do …